𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A kinematic study of progressive apraxia with and without dementia

✍ Scribed by Richard J. Caselli; George E. Stelmach; John N. Caviness; Dagmar Timmann; Todd Royer; Bradley F. Boeve; Joseph E. Parisi


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
153 KB
Volume
14
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


THE EXPERIENCE OF DYING WITH DEMENTIA: A
✍ MARK McCARTHY; JULIA ADDINGTON-HALL; DAN ALTMANN πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

Objective. To describe the last year of life of people with dementia, their symptoms, care needs, use of and satisfaction with health services and the bereavement state of the respondent. Methods. The study is drawn from the Regional Study of Care for the Dying, a retrospective sample survey of the

A pilot study of thalidomide in patients
✍ Danai D. Daliani; Christos N. Papandreou; Peter F. Thall; Xuemei Wang; Cherie Pe πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Background: The highly vascular nature of renal cell carcinoma (rcc) suggests that angiogenesis inhibition may be therapeutic for patients with this disease. thalidomide inhibits basic fibroblast growth factor and vascular endothelial growth factor (vegf)-induced angiogenesis. ## Methods: In a

A PILOT STUDY COMPARING PSYCHOLOGICAL AN
✍ CHANAKA WIJERATNE; SIMON LOVESTONE πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 322 KB πŸ‘ 2 views

A pilot study compared the difficulties faced by co-resident relatives caring for elderly patients with dementia and those with depression, referred to a psychogeriatric service in London. The mean GHQ-28 score of 23 dementia carers was significantly higher than that of 17 carers of elderly people w

Interferon-Ξ±-2a with or without 13-cis r
✍ Sophie D. FossΓ₯; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin